Social Behavior: Clinical Trials

35 trials for Social Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed. 35 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 335Completed 35
Phase 25Completed 5

Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Liposomal Cyclosporine A, standard of care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA622019-03-262025-10-27
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Liposomal Cyclosporine A, Standard of Care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA1692019-03-262026-02-10
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Everolimus, Tacrolimus, Mycophenolate Mofetil - Pediatric Heart Transplantation, Immunosuppression
Phase 3CompletedBoston Children's Hospital2112018-01-292026-07-31
Omega-3 Supplementation and Behavior Problems
Omega-3 supplemented drink, Smartfish - Aggression, Antisocial Behavior
Phase 2 / Phase 3CompletedDr. Annis Fung3242015-02-012018-07-18
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany9392014-01-312017-08-24
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Everolimus, Tacrolimus, Cyclosporin A - Kidney Transplantation, Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals6122012-12-272017-05-01
Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder
Affect Regulation Training - Binge-Eating Disorder
Phase 2 / Phase 3CompletedFriedrich-Alexander-Universität Erlangen-Nürnberg992012-12-172020-08-28
Changing the Vulnerable Brain: A Neuromodulation Study in Alcohol Dependence
Repetitive Transcranial Magnetic Stimulation - Alcohol Dependence
Phase 3CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)802012-02-012015-09-23
"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."
ASSIST-linked brief intervention for hazardous and harmful substance use., Observation - Alcohol-Related Disorders, Substance-Related Disorders
Phase 3CompletedPontificia Universidad Catolica de Chile4002011-12-012013-10-09
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted
Phase 3CompletedMerck KGaA, Darmstadt, Germany2022011-05-312021-05-28
Preventing Aggression in Veterans With Dementia
PAVeD Intervention, Enhanced Usual Care - Dementia, Aggression
Phase 3CompletedVA Office of Research and Development2032011-05-012016-06-24
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Corifollitropin alfa, recFSH (follitropin beta) - Infertility
Phase 3CompletedOrganon and Co3072010-06-022024-06-20
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)
SCH 900962 / Corifollitropin alfa / Org 36286, RecFSH / follitropin beta, Placebo for SCH 900962 - Infertility
Phase 3CompletedOrganon and Co14242010-06-012022-02-03
Donor Simvastatin Treatment in Organ Transplantation
Simvastatin 80mg, Control Rx - Heart Failure, Respiratory Failure
Phase 2 / Phase 3CompletedHelsinki University Central Hospital842010-06-012017-09-19
Effect of Omega-3 Supplementation on Child Behavior Problems
omega-3 - Antisocial, Aggressive
Phase 2 / Phase 3CompletedJoint Child Health Project, Mauritius2002010-03-012013-12-19
Citalopram for Agitation in Alzheimer's Disease
citalopram, placebo - Alzheimer's Disease, Agitation
Phase 3CompletedJHSPH Center for Clinical Trials1862009-07-012014-06-27
Preventing Aggressive Behavior in Demented Patients
Preventing Aggressive Behavior in Demented Patients - Dementia, Aggression
Phase 3CompletedUS Department of Veterans Affairs102009-06-012010-10-18
Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Genetic Counseling - Schizophrenia, Bipolar Disorder
Phase 3CompletedUniversity of British Columbia132008-08-012011-11-23
Impact of Genetic Counseling for Individuals With Mental Illness
Genetic Counseling, Educational Booklet - Schizophrenia, Bipolar Disorder
Phase 3CompletedUniversity of British Columbia1202008-07-012012-07-12
Effectiveness of Treatment for Relational Aggression in Urban African American Girls
Friend to Friend program, Psychoeducational attention control intervention - Aggression
Phase 3CompletedChildren's Hospital of Philadelphia1442007-10-012015-06-04

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Rejection, Psychology (11)  ·  Helping Behavior (10)  ·  Aggression (9)  ·  Infertility (7)  ·  Psychotic Disorders (3)  ·  Antisocial Personality Disorder (2)  ·  Bipolar Disorder (2)  ·  Bronchiolitis Obliterans (2)  ·  Dementia (2)  ·  Emotional Regulation (2)  ·  Schizophrenia (2)  ·  Social Stigma (2)  ·  Alcohol-Related Disorders (1)  ·  Alcoholism (1)  ·  Alzheimer Disease (1)

Broader conditions

Behavior (35)  ·  Mental Disorders (13)  ·  Urogenital Diseases (10)  ·  Aberrant Motor Behavior in Dementia (9)  ·  Behavioral Symptoms (9)  ·  Genital Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Pathologic Processes (4)  ·  Respiratory Tract Diseases (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Chronic Disease (3)

Interventions

Fingolimod Hydrochloride (4)  ·  Chorionic Gonadotropin (3)  ·  Mycophenolic Acid (3)  ·  Ovidrel (3)  ·  Tacrolimus (3)  ·  follitropin alfa (3)  ·  Adrenal Cortex Hormones (2)  ·  Basiliximab (2)  ·  Everolimus (2)  ·  Genetic Counseling (2)  ·  Standard of Care (2)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  follitropin beta (2)  ·  pergoveris (2)  ·  Aripiprazole (1)

Sponsors

Merck KGaA, Darmstadt, Germany (5)  ·  Novartis Pharmaceuticals (5)  ·  Organon and Co (3)  ·  University of British Columbia (2)  ·  Zambon SpA (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Boston Children's Hospital (1)  ·  Children's Hospital of Philadelphia (1)  ·  Christian Medical College, Vellore, India (1)  ·  Dr. Annis Fung (1)  ·  Drexel University (1)  ·  EMD Serono (1)  ·  Friedrich-Alexander-Universität Erlangen-Nürnberg (1)  ·  Helsinki University Central Hospital (1)  ·  Indiana University (1)

Countries

United States (13)  ·  Germany (5)  ·  Canada (4)  ·  France (4)  ·  China (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Denmark (2)  ·  Finland (2)  ·  Israel (2)  ·  Spain (2)  ·  Austria (1)  ·  Chile (1)  ·  Greece (1)  ·  India (1)

Top investigators

Erin Michalak (2)  ·  Huafei Li (2)  ·  Jehannine Austin, PhD, CCGC, CGC (2)  ·  Mark E. Kunik, MD MPH (2)  ·  Paola Castellani, MD (2)  ·  William Honer, MD (2)  ·  Anneke E Goudriaan, Prof dr. (1)  ·  Annis Fung, Ph.D. (1)  ·  Anton Porsteinsson, MD (1)  ·  Bruce Pollock, MD (1)  ·  Catriona Hippman (1)  ·  Catriona Hippman, MSc (1)  ·  Cecilia Chaparro, MD (1)

Results publications

PMID 15940045, PMID 17198261, PMID 17954514, PMID 17984842, PMID 18195237, PMID 22429192, PMID 22467413, PMID 23916527, PMID 24549548, PMID 24914549, PMID 25107934, PMID 25146492, PMID 26003273, PMID 26035086, PMID 26141305, PMID 26194884, PMID 26520396, PMID 26888217, PMID 26930535, PMID 26955380, PMID 26991902, PMID 27090863, PMID 27619773, PMID 28137754, PMID 29699333, PMID 31057439, PMID 31133889, PMID 31352795, PMID 32026743, PMID 33315277, PMID 37158538, PMID 37811711, PMID 38993854, PMID 40960806

NIH funding

2018 (2), R01AG031348 (1), R01MH072961 (1), R01MH075787 (1), R29MH057093 (1)